287 related articles for article (PubMed ID: 28368978)
21. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
Garini G; Allegri L; Vaglio A; Buzio C
Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
[TBL] [Abstract][Full Text] [Related]
22. Managing refractory cryoglobulinemic vasculitis: challenges and solutions.
Ostojic P; Jeremic IR
J Inflamm Res; 2017; 10():49-54. PubMed ID: 28507447
[TBL] [Abstract][Full Text] [Related]
23. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
Cacoub P
Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
[TBL] [Abstract][Full Text] [Related]
24. [Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and a case report].
Filippini D; Colombo F; Jann S; Cornero R; Canesi B
Reumatismo; 2002; 54(2):150-5. PubMed ID: 12105684
[TBL] [Abstract][Full Text] [Related]
25. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
Perez-Alamino R; Espinoza LR
Curr Rheumatol Rep; 2014 May; 16(5):420. PubMed ID: 24647999
[TBL] [Abstract][Full Text] [Related]
26. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus-induced vasculitis: therapeutic options.
Cacoub P; Terrier B; Saadoun D
Ann Rheum Dis; 2014 Jan; 73(1):24-30. PubMed ID: 23921995
[TBL] [Abstract][Full Text] [Related]
29. New insights in cryoglobulinemic vasculitis.
Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
[TBL] [Abstract][Full Text] [Related]
30. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
Iannuzzella F; Garini G
Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis].
Minami Y; Kudo M
Brain Nerve; 2018 Feb; 70(2):133-137. PubMed ID: 29433114
[TBL] [Abstract][Full Text] [Related]
32. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
[TBL] [Abstract][Full Text] [Related]
33. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
[TBL] [Abstract][Full Text] [Related]
34. Clinico-immunological outcomes of HCV-cured cryoglobulinemia: Lower relapse rate with interferon-based than interferon-free therapy.
Colantuono S; Marrapodi R; Del Padre M; Collalti G; Garzi G; De Santis A; Fiorilli M; Basili S; Visentini M; Casato M
Liver Int; 2021 Jan; 41(1):70-75. PubMed ID: 33064930
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
36. [Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia].
Milovanova SIu; Tégaĭ SV; Russkikh AV; Kozlovskaia LV
Ter Arkh; 2011; 83(11):38-43. PubMed ID: 22312883
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Staak JO; Glossmann JP; Diehl V; Josting A
Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
[TBL] [Abstract][Full Text] [Related]
38. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
39. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
[TBL] [Abstract][Full Text] [Related]
40. Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies.
Fabrizi F; Dixit V; Messa P
Acta Gastroenterol Belg; 2013 Dec; 76(4):363-71. PubMed ID: 24592538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
